China Life Insurance
30-Second Executive Brief
Executive Assessment
China Life Insurance functions as a regional institution within Financial Services & Banking, backed by 0% sourcing coverage, with accelerating strategic relevance.
- Maintains 1 mapped relationship across the graph
- 0% sourcing coverage across sourced relationships
- Tracked as regional institution within the Financial Services & Banking category
Executive Snapshot
- Strategic Role
- Regional Institution
- Sourcing Coverage
- 0%
- Ecosystem Influence
- Moderate
- Strategic Momentum
- Accelerating
View Methodology →
Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.
Coverage
- Mapped Relationships
- 1
- Technology Domains
- 4
Strategic Implications
- Central node connecting multiple strategic ecosystems
- Directly influences technology and capital flows
- Material relevance to downstream dependency mapping
Top Opportunities
Top Risks
Critical Dependencies
China's largest state-owned life insurer and institutional investment group; posted record H1 2026 revenue of 434.3 billion yuan (up 81.5% year-over-year) with net profit surging more than 228% to 134.5 billion yuan, and is scaling up investments in AI, chips and biotech.
Additional Intelligence Signals
Patent citation lineage, earnings-call mentions, and federal contract disclosures — automatically collected, not yet visible anywhere else on the site.
Sources
Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.
Evidence
1 source
- South China Morning Post — China Life's revenue surges as top insurer ramps up investment in AI, chips and biotechnews
Acquisition & Investment Fit
AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.
Relationship Map
The relationships surrounding China Life Insurance — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.
Connection type
Click any node to make it the new center. Scroll to zoom, drag to pan.
The Story So Far (last 6 months)
Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.
China Life Insurance's Timeline
A sourced, dated history of China Life Insurance's key moments — founding to present.
Aug 2026 · H1 2026 revenue surges 81.5% to record 434.3 billion yuan
China Life Insurance posted record H1 2026 revenue of 434.3 billion yuan, up 81.5% year-over-year, with net profit surging more than 228% to 134.5 billion yuan, attributed to high-quality development, deeper asset-liability interaction and product diversification, alongside plans to scale up investment in AI, chips and biotech.